FUS and proteostasis deficiencies: Considering the multi-level regulation of FUS gene expression and the diverse genetic background in different individuals, it is conceivable that different mechanisms contribute to the development of FUS-proteinopathies and that HSP60 is not the only modulator of FUS induced neurotoxicity among different FTLD-FUS patients.